When compared to RIA, commercially available fixed CBA appears to have a stronger capacity to identify AChR and MuSK-Ab and may be beneficial as a serological test or a first diagnostic test in patients with double seronegative MG (137). Here, MUSK is linked to myasthenia gravis.